ClinicalTrials.govpublic full text
Letetresgene Autoleucel Engineered T Cells in NY-ESO -1 Positive Advanced Non-Small Cell Lung Cancer (NSCLC)
neoplasms, letetresgene autoleucel, adoptive tcr t-cell therapy, ny-eso-1, t cell receptor, non-small cell lung cancer, leukapheresis, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 884735
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.